| Literature DB >> 25057763 |
Karama Charfi-Kessis1, Wejdene Mansour2, Anis Ben Haj Khalifa3, Maha Mastouri4, Patrice Nordmann5, Mahjoub Aouni4, Laurent Poirel5.
Abstract
Multidrug-resistant and difficult-to-treat Acinetobacter baumannii may be responsible for nosocomial infections. The production of carbapenem-hydrolyzing class D β-lactamases (CHDLs) and extended-spectrum β-lactamase (ESBLs) of the GES type possessing a carbapenemase activity has been increasingly reported worldwide in A. baumannii. The aim of this study was to analyze the resistance mechanisms of two carbapenem resistant A. baumannii clinical isolates recovered in a neonatology center in the center-east of Tunisia. Two carbapenem resistant A. baumannii isolates were recovered. The first isolate co-harbored the blaGES-11 ESBL gene and the blaOxA-23 CHDL gene. Analyses of the genetic location indicated that the blaGES-11 gene was plasmid located (Gr6). However, the blaOxA-23 gene was located on the chromosome. The second strain had only the blaOxA-23 CHDL gene, which was plasmid located. This study showed the first description of the GES-type β-lactamase in A. baumannii in Tunisia.Entities:
Keywords: Acinetobacter baumannii; Carbapenem resistance; GES-11; Neonatology center; OXA-23; Tunisia
Mesh：
Substances：
Year: 2014 PMID： 25057763 DOI： 10.1016/j.micpath.2014.07.003
Source DB: PubMed Journal: Microb Pathog ISSN： 0882-4010 Impact factor: 3.738